Cordance Medical Receives NIH/NCI SBIR Phase I Grant to Advance Non-Invasive Focused Ultrasound for Brain Tumor Liquid Biopsy in Glioma Models
Cordance Medical Announces Triple Patent Grant to Revolutionize Treatment of Brain Diseases with its Innovative NeuroAccess Platform April 17, 2024
Cordance Medical Announces Agreement with Stanford Medicine’s Airan and Williams Labs for Precision Neuropsychiatry with Ultrasonic Drug Uncaging Technology December 6, 2023
Cordance Medical Accepted into Prestigious FDA TAP Program for its NeuroAccess Device December 5, 2023
Cordance Medical’s NeuroAccess Receives FDA Breakthrough Device Designation for Liquid Biopsy in Brain Tumors October 25, 2023
Cordance Medical Joins BLOODPAC to Enable Blood-Based Liquid Biopsy Tests for Brain Tumor Patients October 20, 2023
Cordance Medical Licenses Key Intellectual Property from Washington University to Enhance its NeuroAccess™ Platform September 28, 2023
Cordance Medical and EXACT Therapeutics Announce Strategic Partnership to Revolutionize Drug Delivery to the Brain September 6, 2023
Cordance Medical Welcomes Esteemed Experts Eric Leuthardt, MD, and Hong Chen, PhD, to Advance NeuroAccess Technology for Liquid Biopsy and Drug Delivery in Brain Diseases June 1, 2023
